| 000 | 01782 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516155908.0 | ||
| 264 | 0 | _c20131119 | |
| 008 | 201311s 0 0 eng d | ||
| 022 | _a1107-0625 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aInanc, M | |
| 245 | 0 | 0 |
_aD-dimer is a marker of response to chemotherapy in patients with metastatic colorectal cancer. _h[electronic resource] |
| 260 |
_bJournal of B.U.ON. : official journal of the Balkan Union of Oncology _c |
||
| 300 |
_a391-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntigens, Tumor-Associated, Carbohydrate _xblood |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCA-19-9 Antigen _xblood |
| 650 | 0 | 4 | _aCapecitabine |
| 650 | 0 | 4 |
_aCarcinoembryonic Antigen _xblood |
| 650 | 0 | 4 |
_aCarcinoma _xblood |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xblood |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrin Fibrinogen Degradation Products _xanalysis |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aOxaloacetates |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTurkey |
| 700 | 1 | _aEr, O | |
| 700 | 1 | _aKaraca, H | |
| 700 | 1 | _aBerk, V | |
| 700 | 1 | _aOzkan, M | |
| 700 | 1 | _aDikilitas, M | |
| 700 | 1 | _aElmali, F | |
| 773 | 0 |
_tJournal of B.U.ON. : official journal of the Balkan Union of Oncology _gvol. 18 _gno. 2 _gp. 391-7 |
|
| 999 |
_c22883623 _d22883623 |
||